Decibel Therapeutics
(NASDAQ) DBTX
Decibel Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$63.39M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
DBTX News
DBTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Decibel Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
68
CEO
Laurence E. Reid, PhD
Website
www.decibeltx.comHeadquarters
Boston, MA 02215, US
DBTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-63%
Return on Assets
-51%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$63.96M
EBITDA
$60.11M
Operating Cash Flow
$56.90M
Capital Expenditure
$463.00K
Free Cash Flow
$57.36M
Cash & ST Invst.
$104.56M
Total Debt
$14.05M
Decibel Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
68
N/A
Net Income
$18.14M
-6.4%
EBITDA
$18.72M
-13.1%
Quarterly Fundamentals
Net Cash
$65.45M
-40.6%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$9.18M
-21.7%
Short Term Debt
$3.66M
+0.4%
Return on Assets
-51.07%
N/A
Return on Invested Capital
-63.37%
N/A
Free Cash Flow
$10.26M
+24.2%
Operating Cash Flow
$10.27M
+23.4%